Sonoma Pharma terminates EVP/COO Bruce Thornton for cause, effective Oct 18

Sonoma Pharmaceuticals, Inc.

Bruce Thornton terminated as EVP and Chief Operating Officer on October 18, 2025.
Termination was for cause under his employment agreement; no severance or future benefits.
Thornton will only receive salary and benefits earned through the termination date.
CEO Amy Trombly signed the 8-K confirming the departure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.